Therefore, miR-128 regulated the infiltration of anti-tumor immune cells, including DCs, CD8+ T cells, and NKT cells, in the immune microenvironment through the ZEB1/CD47 axis, accompanied by the inhibition of the EMT process through ZEB1, ultimately inhibiting tumor growth and metastasis. Here, ZEB1 is linked to neoplasm.